Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks
Things are going from bad to worse for Sarepta Therapeutics (NASDAQ: SRPT), a biotech focusing on gene therapies. The company's performance over the past six months had already been unimpressive. But on...
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)
Jefferies acknowledged acute liver failure could signal a new safety risk but maintained that the high unmet need for DMD treatments supports the bull case.
Shares of Sarepta Therapeutics, Inc. SRPT plunged 27.4% after the company reported a patient death linked to its Elevidys gene therapy, sparking safety concerns.IHS Holding Limited IHS shares surged 13.2%...
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -1.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.62%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.66%. March E-mini...
A patient has died while taking a closely watched gene therapy for muscular dystrophy
Why Sarepta Therapeutics (SRPT) Shares Are Sliding Today
The S&P 500 Index ($SPX ) (SPY ) today is down -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.89%. March E-mini S&P futures...
The S&P 500 Index ($SPX ) (SPY ) today is down -1.01%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.50%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.73%. March E-mini S&P futures...